Faculty profile

Erika Penz

ResearcherMedicineUniversity of Saskatchewan

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses may be missing. Find their university profile.

Erika Penz

Researcher

Medicine

Health Sciences

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
34 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.
Supervised 1 trainee who won CIHR awards, most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

336

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Pathway Learning Health Systems Long Covid Patient-Oriented Research Realist Evaluation Administrative Data Analysis Burden Of Illness Study Health Economics Analysis

Latest papers

Vaping: Respiratory Impacts and Public Health Challenges in the Americas.
Annals of the American Thoracic Society · 2026
Clinical Remission with FF/UMEC/VI Versus ICS/LABA in Uncontrolled Asthma: The PERFORM Pragmatic Randomized Controlled Trial.
Advances in therapy · 2026 · senior author
Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.
The Journal of asthma : official journal of the Association for the Care of Asthma · 2026

All 57 publications

Latest funding

'Hope through Strength': Using a Social Return on Investment Analysis to Represent a Wholistic View of the Value Produced through Investing in the first HIV Prenatal Care Home in Canada, Sanctum 1.5
CIHR · 2022 · Supervisor
$108,500
Integrated Care Clinical Pathway Implementation using a Patient Oriented Learning Health System Approach: A Realist Process Evaluation of the Saskatchewan Long COVID Pathway
CIHR · 2022 · Principal investigator
$1,961,649
Sanctum 1.5's hope through strength: A novel, women-directed and community-based approach to wholistic care for mother-infant pairs experiencing a substance use disorder and/or HIV
CIHR · 2019 · Co-investigator
$1,231,652

All 4 grants and awards

57 publications.

Vaping: Respiratory Impacts and Public Health Challenges in the Americas.

Noël A, Kathuria H, Penz E, Rendón A, Scuarcialupi ME, Lang AE, Moraes TJ, Almonte F, Barreto Machado Costa PF, Celedón JC, Crotty Alexander LE

Annals of the American Thoracic Society2026

DOI: 10.1093/annalsats/aaoag211 PMID: 42770836

Clinical Remission with FF/UMEC/VI Versus ICS/LABA in Uncontrolled Asthma: The PERFORM Pragmatic Randomized Controlled Trial.

Noorduyn SG, Oppenheimer JJ, Moore AC, Nagase H, Crawford J, Poddar A, Boon V, Brown N, Slade D, Garcia G, Baptist AP, Penz E

Advances in therapy2026Senior author

DOI: 10.1007/s12325-026-03721-1 PMID: 42474701

Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.

Lommatzsch M, Penz E, Dupont L, Tran TN, Menzies-Gow A, Shavit A, Cohen D, Plate T, Hamilton MA, Quataert C, Schuoler C, Rothe T, Emmanuel B

The Journal of asthma : official journal of the Association for the Care of Asthma2026

DOI: 10.1080/02770903.2026.2696569 PMID: 42384831

A Conversation Aid for Climate Conscious Inhaler Prescribing.

Butler SJ, Ning T, Balaci GA, Li T, Tse SM, Digby G, Lam I, Hubick J, Penz E, Singer A, Kaplan A, O'Keefe A, Walji S, Green S, Culley C, Stoynova V, Kouri A, Gupta S

Chest2026

DOI: 10.1016/j.chest.2026.06.005 PMID: 42297235

Understanding inhaler users' perceptions of climate change and inhaler carbon footprints: insights from a Canadian survey.

Butler SJ, Digby GC, Roy C, Tse SM, Sajwani S, Hubick J, McCoy C, Lam I, Singer A, Kaplan A, Leek E, Walji S, Stoynova V, Penz E, Gupta S

BMJ open respiratory research2026

DOI: 10.1136/bmjresp-2025-003880 PMID: 42103366

Effectiveness of FF/UMEC/VI versus ICS/LABA in Patients with Uncontrolled Asthma Treated in Routine Clinical Practice (PERFORM): A Pragmatic Randomized Controlled Trial.

Penz E, Noorduyn SG, Moore AC, Nagase H, Crawford J, Woessner M, Demetriou L, Brown N, Slade D, Garcia G, Baptist AP, Oppenheimer JJ

Journal of asthma and allergy2026First author

DOI: 10.2147/jaa.s599766 PMID: 42125304

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.

Penz E, Rothe T, Dupont L, Tran TN, Menzies-Gow A, Shavit A, Cohen D, Plate T, Kayaniyil S, Herreman A, Schuoler C, Emmanuel B, Lommatzsch M

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026First author

DOI: 10.1111/cea.70162 PMID: 41162224

Mepolizumab reduced healthcare resource utilization and improved work productivity in patients with severe asthma during the REALITI-A 2-year study.

Canonica GW, Bourdin A, Penz E, Zhang L, Howarth P, Alfonso-Cristancho R

The Journal of asthma : official journal of the Association for the Care of Asthma2025

DOI: 10.1080/02770903.2025.2558755 PMID: 40991264

Future exacerbations and mortality rates among patients experiencing COPD exacerbations: a meta-analysis of results from the EXACOS/AVOIDEX programme

Rhodes K, Patel D, Duong ML, Haughney J, Make BJ, Marshall J, Penz E, Santus P, Sethi S, Soler-Cataluña JJ

BMJ Open202512 citations

DOI: 10.1136/bmjopen-2024-097006

Patient Factors and Clinical Efficacy of Early Identification and Treatment of Chronic Obstructive Pulmonary Disease and Asthma

Tardif A, Whitmore GA, Vandemheen KL, Bergeron C, Boulet L-P, Cote A, McIvor RA, Penz E, Field SK, Lemière C

American Journal of Respiratory and Critical Care Medicine20254 citations

DOI: 10.1164/rccm.202505-1260oc

Something wrong or missing on this profile? Suggest a correction

Erika Penz

Research

Latest papers

Latest funding

Vaping: Respiratory Impacts and Public Health Challenges in the Americas.

Clinical Remission with FF/UMEC/VI Versus ICS/LABA in Uncontrolled Asthma: The PERFORM Pragmatic Randomized Controlled Trial.

Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.

A Conversation Aid for Climate Conscious Inhaler Prescribing.

Understanding inhaler users' perceptions of climate change and inhaler carbon footprints: insights from a Canadian survey.

Effectiveness of FF/UMEC/VI versus ICS/LABA in Patients with Uncontrolled Asthma Treated in Routine Clinical Practice (PERFORM): A Pragmatic Randomized Controlled Trial.

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.

Mepolizumab reduced healthcare resource utilization and improved work productivity in patients with severe asthma during the REALITI-A 2-year study.

Future exacerbations and mortality rates among patients experiencing COPD exacerbations: a meta-analysis of results from the EXACOS/AVOIDEX programme

Patient Factors and Clinical Efficacy of Early Identification and Treatment of Chronic Obstructive Pulmonary Disease and Asthma

'Hope through Strength': Using a Social Return on Investment Analysis to Represent a Wholistic View of the Value Produced through Investing in the first HIV Prenatal Care Home in Canada, Sanctum 1.5

Integrated Care Clinical Pathway Implementation using a Patient Oriented Learning Health System Approach: A Realist Process Evaluation of the Saskatchewan Long COVID Pathway

Sanctum 1.5's hope through strength: A novel, women-directed and community-based approach to wholistic care for mother-infant pairs experiencing a substance use disorder and/or HIV

The Rising Burden of Lung Cancer: An Inter-provincial Health Economic Analysis

Frequent collaborators

Samir Gupta

Sunita Mulpuru

Andrew McIvor

Donna Goodridge

Nicole Ezer

Gary Groot

Catherine Trask

Thomas Rotter

Tetyana Kendzerska

Brenna Bath

Jean Bourbeau

Samantha Green

Huiming Yang

Paul Babyn

Huiming Yang

Alexander Singer

David Blackburn

Antoine Dufour

Daniela Pohl

Chung-Chun Tyan

Sonya Cressman

Samir Gupta

Céline Bergeron

Sonya Cressman

Erika Penz

Maziar Divangahi

Mylinh Duong

Roy Dobson

Marla Beauchamp

Michael Stickland

Joshua Lawson

Joshua Wald